Diagnostic Accuracy of Serological Tests for Mycoplasma pneumoniae Infections in Children with Pneumonia, Based on Symptom Onset
- Author:
Gahee KIM
1
;
Ki Wook YUN
;
Dayun KANG
;
Taek Jin LEE
;
Byung Wook EUN
;
Hyunju LEE
;
Yae-Jean KIM
;
Doo Ri KIM
;
Areum SHIN
;
Hyun Mi KANG
;
Ye Ji KIM
;
Byung Ok KWAK
;
Younghee LEE
;
Ye Kyung KIM
;
Young June CHOE
;
Woosuck SUH
;
Kyo Jin JO
;
Kyung-Ran KIM
;
Eun Young CHO
;
Kyung Min KIM
;
Joon Kee LEE
;
Su Eun PARK
Author Information
- Publication Type:Original Article
- From:Annals of Laboratory Medicine 2026;46(2):162-170
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Mycoplasma pneumoniae is a major cause of community-acquired pneumonia (CAP) in children, with a rising incidence of macrolide resistance. Early diagnosis is crucial for reducing the disease burden; however, current diagnostic tools have limitations.We evaluated the diagnostic accuracy of serological assays and their performance based on symptom onset in children with CAP.
Methods:From September 2023 to September 2024, we prospectively enrolled children with CAP, classified as M. pneumoniae pneumonia (MPP) or non-MPP, from 16 hospitals in Korea. Serological testing included chemiluminescence immunoassay (CLIA) and ELISA for detecting IgM and IgG, along with particle agglutination (PA) for total antibody measurements. Serological responses were analyzed at different times after symptom onset (0–4, 5–9, and 10–21 days).
Results:Among 472 children with CAP (362 MPP, 110 non-MPP), 138 (29.2%) underwent PA testing, and 334 (70.8%) underwent IgM testing. PA at a 1:640 cutoff showed 48.0% sensitivity and 100% specificity. CLIA and ELISA showed comparable sensitivities (69.1% vs. 69.2%) and specificities (76.9% vs. 66.7%) for IgM testing. Seropositivity increased significantly with time since symptom onset (P for trend < 0.001), reaching 97.9% for IgM, 62.5% for IgG, and 94.7% for PA at 10–21 days.
Conclusions:The time post-symptom onset significantly influenced the diagnostic utility of serological tests for pediatric MPP, which showed limited value during the early stage of illness. These findings emphasize the importance of symptom onset-based interpretation of serological test results and their utility in complementing PCR when optimizing MPP diagnosis in children.
